首页 > 最新文献

Revista Espanola De Medicina Nuclear E Imagen Molecular最新文献

英文 中文
Detección incidental de metástasis óseas de cáncer gástrico en una gammagrafía dinámica renal (renograma) con [99mTc]Tc-DTPA 使用[99mTc]Tc-DTPA进行动态肾x射线照相(核磁共振成像)检测胃癌骨转移的附带情况
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2026-01-01 DOI: 10.1016/j.remn.2025.500196
C. Nong, Y. Xing, L. Jiang, Z. Zhao
{"title":"Detección incidental de metástasis óseas de cáncer gástrico en una gammagrafía dinámica renal (renograma) con [99mTc]Tc-DTPA","authors":"C. Nong, Y. Xing, L. Jiang, Z. Zhao","doi":"10.1016/j.remn.2025.500196","DOIUrl":"10.1016/j.remn.2025.500196","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"45 1","pages":"Article 500196"},"PeriodicalIF":1.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146006833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacto de la infiltración periganglionar en la recurrencia del carcinoma papilar de tiroides 神经节周浸润对甲状腺乳头状瘤复发的影响
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2026-01-01 DOI: 10.1016/j.remn.2025.500182
A. Cinar , U.M. Turan , K. Okuyucu , N. Aydinbelge Dizdar , A. Erol , B. Bedi Alpay , P. Akkus Gunduz , M. Ozkara , D. Cayir , E. Alagoz , S. Ince

Introduction and objectives

Locoregional recurrence occurs in up to 28% of patients with papillary thyroid cancer (PTC). Several risk factors contribute to this metastatic process. The latest of them is perinodal infiltration (PNI). PNI refers to the pathological extension of tumor cells through the lymph node (LN) capsule into the perinodal fibroadipose tissue. It has been accepted as a poor predictive variable. This study aimed to evaluate the prognostic significance of PNI in recurrence of PTC and identify predictive parameters associated with the recurrence in PNI (+) patients.

Material and methods

The study included 680 PTC patients with initial LN metastasis (ILNM). Study population was selected from them according to presence or absence of PNI. Eventually, 102 PNI (+) and 122 PNI (−) patients remained eligible for the study. Patients were statistically compared according to demographic, clinicopathologic features both between PNI (+) and PNI (−) groups and within the PNI (+) group over recurrence status.

Results

The recurrence rates were 40% and 15% in PNI (+) and PNI (−) patients, respectively (P<.001). The independent predictive factors associated with recurrence were central ILNM (P=.005), combined central and lateral ILNM (P=.003), ILNM> 5 (P=.023), stage III-IV (P=.025 and P<.001), tumor size (TS) (P<.001), ILNM size (P<.001), stimulated thyroglobulin (sTg) (P=.039). PNI (P=.05), central ILNM (P=.035) and TS (P=.027) remained prognostic variables after multivariate analysis.

Conclusion

PNI positivity is a poor prognostic factor for PTC recurrence. PNI, especially with large TS and central ILNM, should be taken into account when planning RAI therapy in PTC patients.
简介和目的甲状腺乳头状癌(PTC)患者的局部复发发生率高达28%。几个危险因素有助于这种转移过程。其中最新的是周淋巴结浸润(PNI)。PNI是指肿瘤细胞通过淋巴结(LN)囊进入结周纤维脂肪组织的病理性扩展。它被认为是一个很差的预测变量。本研究旨在评估PNI在PTC复发中的预后意义,并确定与PNI(+)患者复发相关的预测参数。材料与方法本研究纳入680例原发性淋巴结转移(ILNM)的PTC患者。根据是否存在PNI从他们中选择研究人群。最终,102名PNI(+)和122名PNI(-)患者仍符合研究条件。根据人口学、临床病理特征对PNI(+)组和PNI(-)组之间以及PNI(+)组内患者的复发情况进行统计学比较。结果PNI(+)和PNI(-)患者复发率分别为40%和15% (p < 0.001)。与复发相关的独立预测因素为中枢性ILNM (P= 0.005)、中枢性和外侧性ILNM合并(P= 0.003)、ILNM> 5 (P= 0.023)、III-IV期(P= 0.025和P - lt; 0.001)、肿瘤大小(TS) (P - lt; 0.001)、ILNM大小(P - lt; 0.001)、促甲状腺球蛋白(sTg) (P= 0.039)。多因素分析后,PNI (P= 0.05)、中枢性ILNM (P= 0.035)和TS (P= 0.027)仍是预后变量。结论pni阳性是PTC复发的不良预后因素。PNI,特别是大TS和中枢性ILNM,在规划PTC患者的RAI治疗时应考虑到。
{"title":"Impacto de la infiltración periganglionar en la recurrencia del carcinoma papilar de tiroides","authors":"A. Cinar ,&nbsp;U.M. Turan ,&nbsp;K. Okuyucu ,&nbsp;N. Aydinbelge Dizdar ,&nbsp;A. Erol ,&nbsp;B. Bedi Alpay ,&nbsp;P. Akkus Gunduz ,&nbsp;M. Ozkara ,&nbsp;D. Cayir ,&nbsp;E. Alagoz ,&nbsp;S. Ince","doi":"10.1016/j.remn.2025.500182","DOIUrl":"10.1016/j.remn.2025.500182","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Locoregional recurrence occurs in up to 28% of patients with papillary thyroid cancer (PTC). Several risk factors contribute to this metastatic process. The latest of them is perinodal infiltration (PNI). PNI refers to the pathological extension of tumor cells through the lymph node (LN) capsule into the perinodal fibroadipose tissue. It has been accepted as a poor predictive variable. This study aimed to evaluate the prognostic significance of PNI in recurrence of PTC and identify predictive parameters associated with the recurrence in PNI (+) patients.</div></div><div><h3>Material and methods</h3><div>The study included 680 PTC patients with initial LN metastasis (ILNM). Study population was selected from them according to presence or absence of PNI. Eventually, 102 PNI (+) and 122 PNI (−) patients remained eligible for the study. Patients were statistically compared according to demographic, clinicopathologic features both between PNI (+) and PNI (−) groups and within the PNI (+) group over recurrence status.</div></div><div><h3>Results</h3><div>The recurrence rates were 40% and 15% in PNI (+) and PNI (−) patients, respectively (<em>P</em>&lt;.001). The independent predictive factors associated with recurrence were central ILNM (<em>P</em>=.005), combined central and lateral ILNM (<em>P</em>=.003), ILNM&gt;<!--> <!-->5 (<em>P</em>=.023), stage III-IV (<em>P</em>=.025 and <em>P</em>&lt;.001), tumor size (TS) (<em>P</em>&lt;.001), ILNM size (<em>P</em>&lt;.001), stimulated thyroglobulin (sTg) (<em>P</em>=.039). PNI (<em>P</em>=.05), central ILNM (<em>P</em>=.035) and TS (<em>P</em>=.027) remained prognostic variables after multivariate analysis.</div></div><div><h3>Conclusion</h3><div>PNI positivity is a poor prognostic factor for PTC recurrence. PNI, especially with large TS and central ILNM, should be taken into account when planning RAI therapy in PTC patients.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"45 1","pages":"Article 500182"},"PeriodicalIF":1.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146006829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Respuesta a la carta sobre la «Evaluación del papel de la sarcopenia y los parámetros PET/TC con [18F]FDG en el pronóstico del adenocarcinoma ductal de páncreas» 回复:对“肌萎缩症和[18F]FDG PET/TC参数在导管胰腺腺癌预后中的作用评估”这封信的答复
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-01 DOI: 10.1016/j.remn.2025.500164
H. Önner, M.N. Calderon-Tobar, L. Perktaş, F. Yilmaz, G. Kara Gedіk
{"title":"Re: Respuesta a la carta sobre la «Evaluación del papel de la sarcopenia y los parámetros PET/TC con [18F]FDG en el pronóstico del adenocarcinoma ductal de páncreas»","authors":"H. Önner,&nbsp;M.N. Calderon-Tobar,&nbsp;L. Perktaş,&nbsp;F. Yilmaz,&nbsp;G. Kara Gedіk","doi":"10.1016/j.remn.2025.500164","DOIUrl":"10.1016/j.remn.2025.500164","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 6","pages":"Article 500164"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145468987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparación de imágenes de 99mTc-HYNIC-PSMA-11, gammagrafía ósea e investigación posterior a la terapia con radioligandos en los pacientes con CPRCm: experiencia de un solo centro CPRCm患者的99mTc-HYNIC-PSMA-11成像、X射线造影和放射配体治疗后研究比较:单一中心经验
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-01 DOI: 10.1016/j.remn.2025.500157
K. Aryana , A. Aghaee , E. Askari , Y. Fakhar , N. Raeisi , M. Mottaghi , M. Emadzadeh , H. Ghorbani , S Barashki

Background

Prostate-Specific Membrane Antigen is overexpressed in primary and metastatic prostate cancer tissues. While PSMA PET agents have gained their role in the prostate cancer guidelines, Technetium-based PSMA agents have left behind. Given the novelty of 99mTc-HYNIC-PSMA-11, we conducted this study to compare its detection rate in tracing skeletal metastases in comparison to bone scans and also compared the number of metastatic lesions which showed PSMA uptake in the diagnostic scan with those detected in post-treatment scans after radioligand therapy (RLT) with 177Lu-PSMA-617-617.

Methods

Bone and 99mTc-HYNIC-PSMA-11 scans with a maximum interval of 90 days were performed in thirty-nine patients with widespread bone metastases. If the PSMA scan was positive, patients were treated with 177Lu-PSMA-617 and post treatment scan was also obtained. For negative PSMA results, 68Ga-PSMA PET/CT was performed to compare its results with the bone scan. In patients with PSMA expression, detection of metastatic lesions in three consecutive whole-body scans in different regions were compared (99mTc-HYNIC-PSMA-11 with bone and post treatment scans, separately).

Results

Thirty-seven (94.9%) showed adequate 99mTc-HYNIC-PSMA-11 uptake in the metastatic regions. Compared to bone scan, 99mTc-HYNIC-PSMA-11 showed additional lesions in 13 (35.1%) participants which were mostly located in the appendicular skeleton and pelvic bones. Inversely, the bone scan detected more lesions in 12 (32.4%) patients. Both scans in 12 (32.4%) patients showed the exact same results. Comparison between the 99mTc-HYNIC-PSMA-11 scan and 177Lu-PSMA-617 showed completely similar results in 29 (78.4%) patients; however, 177Lu-PSMA-617 detected more lesions in eight (21.6%) participants.

Conclusion

The 99mTc-HYNIC-PSMA-11 scan demonstrates comparable results to bone scans in evaluating skeletal metastases in prostate cancer patients. It serves as a cost-effective modality for identifying suitable candidates for radioligand therapy, particularly beneficial in resource-limited countries.
前列腺特异性膜抗原在原发性和转移性前列腺癌组织中过表达。虽然PSMA PET制剂已经在前列腺癌指南中发挥了作用,但基于锝的PSMA制剂却落在了后面。鉴于99mtc - hylic -PSMA-11的新颖性,我们进行了这项研究,比较了它在追踪骨骼转移方面的检出率与骨扫描的比较,并比较了在诊断扫描中显示PSMA摄取的转移病灶数量与使用177Lu-PSMA-617-617放射配体治疗(RLT)后的治疗后扫描中发现的转移病灶数量。方法对39例广泛骨转移患者进行骨和99mTc-HYNIC-PSMA-11扫描,最长间隔为90天。如果PSMA扫描呈阳性,则患者接受177Lu-PSMA-617治疗,并获得治疗后扫描。对于PSMA阴性结果,进行68Ga-PSMA PET/CT与骨扫描结果进行比较。在PSMA表达的患者中,比较了连续三次全身扫描在不同区域的转移病灶检测(99mTc-HYNIC-PSMA-11分别与骨扫描和治疗后扫描)。结果37例(94.9%)肿瘤转移区99mTc-HYNIC-PSMA-11摄取充足。与骨扫描相比,99mTc-HYNIC-PSMA-11在13名(35.1%)参与者中显示额外的病变,主要位于阑尾骨骼和骨盆骨。相反,在12例(32.4%)患者中,骨扫描检测到更多病变。12例(32.4%)患者的两次扫描结果完全相同。99mTc-HYNIC-PSMA-11扫描与177Lu-PSMA-617的比较显示,29例(78.4%)患者的结果完全相似;然而,177Lu-PSMA-617在8名(21.6%)参与者中检测到更多病变。结论99mTc-HYNIC-PSMA-11扫描在评估前列腺癌患者骨骼转移方面的结果与骨扫描相当。它是一种具有成本效益的方式,用于确定放射治疗的合适候选人,在资源有限的国家特别有益。
{"title":"Comparación de imágenes de 99mTc-HYNIC-PSMA-11, gammagrafía ósea e investigación posterior a la terapia con radioligandos en los pacientes con CPRCm: experiencia de un solo centro","authors":"K. Aryana ,&nbsp;A. Aghaee ,&nbsp;E. Askari ,&nbsp;Y. Fakhar ,&nbsp;N. Raeisi ,&nbsp;M. Mottaghi ,&nbsp;M. Emadzadeh ,&nbsp;H. Ghorbani ,&nbsp;S Barashki","doi":"10.1016/j.remn.2025.500157","DOIUrl":"10.1016/j.remn.2025.500157","url":null,"abstract":"<div><h3>Background</h3><div>Prostate-Specific Membrane Antigen is overexpressed in primary and metastatic prostate cancer tissues. While PSMA PET agents have gained their role in the prostate cancer guidelines, Technetium-based PSMA agents have left behind. Given the novelty of <sup>99m</sup>Tc-HYNIC-PSMA-11, we conducted this study to compare its detection rate in tracing skeletal metastases in comparison to bone scans and also compared the number of metastatic lesions which showed PSMA uptake in the diagnostic scan with those detected in post-treatment scans after radioligand therapy (RLT) with <sup>177</sup>Lu-PSMA-617-617.</div></div><div><h3>Methods</h3><div>Bone and <sup>99m</sup>Tc-HYNIC-PSMA-11 scans with a maximum interval of 90 days were performed in thirty-nine patients with widespread bone metastases. If the PSMA scan was positive, patients were treated with <sup>177</sup>Lu-PSMA-617 and post treatment scan was also obtained. For negative PSMA results, <sup>68</sup>Ga-PSMA PET/CT was performed to compare its results with the bone scan. In patients with PSMA expression, detection of metastatic lesions in three consecutive whole-body scans in different regions were compared (<sup>99m</sup>Tc-HYNIC-PSMA-11 with bone and post treatment scans, separately).</div></div><div><h3>Results</h3><div>Thirty-seven (94.9%) showed adequate <sup>99m</sup>Tc-HYNIC-PSMA-11 uptake in the metastatic regions. Compared to bone scan, <sup>99m</sup>Tc-HYNIC-PSMA-11 showed additional lesions in 13 (35.1%) participants which were mostly located in the appendicular skeleton and pelvic bones. Inversely, the bone scan detected more lesions in 12 (32.4%) patients. Both scans in 12 (32.4%) patients showed the exact same results. Comparison between the <sup>99m</sup>Tc-HYNIC-PSMA-11 scan and <sup>177</sup>Lu-PSMA-617 showed completely similar results in 29 (78.4%) patients; however, <sup>177</sup>Lu-PSMA-617 detected more lesions in eight (21.6%) participants.</div></div><div><h3>Conclusion</h3><div>The 99mTc-HYNIC-PSMA-11 scan demonstrates comparable results to bone scans in evaluating skeletal metastases in prostate cancer patients. It serves as a cost-effective modality for identifying suitable candidates for radioligand therapy, particularly beneficial in resource-limited countries.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 6","pages":"Article 500157"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145468993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Puntuaciones semicuantitativas de la MIBG en el neuroblastoma recidivante/refractario: perspectivas pronósticas de la gammagrafía con [131I]MIBG postratamiento e impacto de las imágenes SPECT/TC MIBG在复发/难治性神经母细胞瘤中的半定量分数:治疗后使用[131I]MIBG的放射学预测前景和SPECT/ CT成像的影响
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-01 DOI: 10.1016/j.remn.2025.500133
M.E. Mavi , P. Özgen-Kiratli , A. Varan , B. Volkan-Salanci

Objectives

Neuroblastoma often demonstrates high uptake of MIBG, which is used for imaging and therapy. This retrospective observational study aimed to assess the prognostic significance of modified Curie scores (mCS) and SIOPEN scores (SS) derived from post-treatment 131I-MIBG scans in relapsed/refractory neuroblastoma. Additionally, the impact of SPECT/CT imaging on these scores was investigated as a secondary goal.

Material and methods

Pediatric patients with relapsed/refractory neuroblastoma, who underwent 131I-MIBG treatment, were included (n = 35). mCS and SS were calculated from planar images of post-treatment 131I-MIBG scans. Patients were then categorized based on the cut-off values obtained from these scans, and survival analysis was conducted. To investigate the impact of SPECT/CT imaging on scores, mCS and SS were also calculated from both planar and SPECT/CT images of diagnostic 123I-MIBG scans separately.

Results

Patients with mCS >12 or SS >23 on post-treatment 131I-MIBG scans had significantly worse overall survival. mCS and SS from SPECT/CT were significantly higher than planar images in pre- and post-treatment diagnostic 123I-MIBG scans. SPECT/CT caused changes in mCS for 61% and SS for 55% of patients, predominantly in axial and appendicular skeleton regions.

Conclusions

Both mCS and SS from post-treatment 131I-MIBG planar scans correlated significantly with overall survival in relapsed/refractory neuroblastoma. Patients with mCS >12 or SS >23 had poorer survival. SPECT/CT imaging influenced scores for a substantial portion of patients, emphasizing its value alongside planar imaging. Larger, comprehensive studies are warranted to validate these findings and refine prognostic cut-offs. Incorporating SPECT/CT in relevant body regions is recommended for improved disease assessment.
目的神经母细胞瘤通常表现为MIBG的高摄取,用于成像和治疗。这项回顾性观察性研究旨在评估治疗后131I-MIBG扫描得出的改良Curie评分(mCS)和SIOPEN评分(SS)对复发/难治性神经母细胞瘤的预后意义。此外,将SPECT/CT成像对这些评分的影响作为次要目标进行研究。材料和方法采用131I-MIBG治疗的复发/难治性神经母细胞瘤儿童患者(n = 35)。从处理后的131I-MIBG扫描平面图像计算mCS和SS。然后根据这些扫描获得的临界值对患者进行分类,并进行生存分析。为了研究SPECT/CT成像对评分的影响,还分别从诊断性123I-MIBG扫描的平面和SPECT/CT图像计算mCS和SS。结果治疗后131I-MIBG扫描mCS >;12或SS >;23的患者总生存期明显较差。在诊断性123I-MIBG扫描前和治疗后,SPECT/CT的mCS和SS明显高于平面图像。SPECT/CT导致61%的患者mCS改变,55%的患者SS改变,主要发生在轴向和附肢骨骼区域。结论治疗后131I-MIBG平面扫描的mCS和SS与复发/难治性神经母细胞瘤的总生存率显著相关。mCS >;12或SS >;23患者生存率较差。SPECT/CT成像影响了相当一部分患者的评分,强调了其与平面成像的价值。有必要进行更大规模、更全面的研究来验证这些发现,并完善预后临界值。建议在相关身体区域结合SPECT/CT来改进疾病评估。
{"title":"Puntuaciones semicuantitativas de la MIBG en el neuroblastoma recidivante/refractario: perspectivas pronósticas de la gammagrafía con [131I]MIBG postratamiento e impacto de las imágenes SPECT/TC","authors":"M.E. Mavi ,&nbsp;P. Özgen-Kiratli ,&nbsp;A. Varan ,&nbsp;B. Volkan-Salanci","doi":"10.1016/j.remn.2025.500133","DOIUrl":"10.1016/j.remn.2025.500133","url":null,"abstract":"<div><h3>Objectives</h3><div>Neuroblastoma often demonstrates high uptake of MIBG, which is used for imaging and therapy. This retrospective observational study aimed to assess the prognostic significance of modified Curie scores (mCS) and SIOPEN scores (SS) derived from post-treatment <sup>131</sup>I-MIBG scans in relapsed/refractory neuroblastoma. Additionally, the impact of SPECT/CT imaging on these scores was investigated as a secondary goal.</div></div><div><h3>Material and methods</h3><div>Pediatric patients with relapsed/refractory neuroblastoma, who underwent <sup>131</sup>I-MIBG treatment, were included (n<!--> <!-->=<!--> <!-->35). mCS and SS were calculated from planar images of post-treatment <sup>131</sup>I-MIBG scans. Patients were then categorized based on the cut-off values obtained from these scans, and survival analysis was conducted. To investigate the impact of SPECT/CT imaging on scores, mCS and SS were also calculated from both planar and SPECT/CT images of diagnostic <sup>123</sup>I-MIBG scans separately.</div></div><div><h3>Results</h3><div>Patients with mCS<!--> <!-->&gt;12 or SS<!--> <!-->&gt;23 on post-treatment <sup>131</sup>I-MIBG scans had significantly worse overall survival. mCS and SS from SPECT/CT were significantly higher than planar images in pre- and post-treatment diagnostic <sup>123</sup>I-MIBG scans. SPECT/CT caused changes in mCS for 61% and SS for 55% of patients, predominantly in axial and appendicular skeleton regions.</div></div><div><h3>Conclusions</h3><div>Both mCS and SS from post-treatment <sup>131</sup>I-MIBG planar scans correlated significantly with overall survival in relapsed/refractory neuroblastoma. Patients with mCS<!--> <!-->&gt;12 or SS<!--> <!-->&gt;23 had poorer survival. SPECT/CT imaging influenced scores for a substantial portion of patients, emphasizing its value alongside planar imaging. Larger, comprehensive studies are warranted to validate these findings and refine prognostic cut-offs. Incorporating SPECT/CT in relevant body regions is recommended for improved disease assessment.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 6","pages":"Article 500133"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145468997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exactitud diagnóstica del cociente tiroides/fondo para diferenciar la enfermedad de Graves de la tiroiditis subaguda: estudio comparativo 区分严重疾病与亚急性甲状腺炎的甲状腺比值/深度的诊断准确性:比较研究
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-01 DOI: 10.1016/j.remn.2025.500199
G. Silov , F. Bati , N. Biçakçi , B. Kirtiloğlu , M. Yilmaz
<div><h3>Background and objective</h3><div>Thyrotoxicosis is a common clinical condition in endocrinology, with Graves’ disease (GD) and subacute thyroiditis (SAT) as its predominant causes. These disorders often share overlapping clinical and biochemical features, making differential diagnosis challenging. This study evaluates the diagnostic efficacy of the thyroid/background ratio (TBR) as a semiquantitative method for differentiating GD from SAT and compares multiple diagnostic parameters.</div></div><div><h3>Materials and methods</h3><div>This was a retrospective analysis of 106 consecutive patients newly diagnosed with thyrotoxicosis. All participants underwent assessment of free tri-iodothyronine (fT3), free thyroxine (fT4), TSH, thyroid-stimulating immunoglobulin (TSI), Anti-TPO, Anti-Tg, CRP, erythrocyte sedimentation rate (ESR), <sup>99m</sup>Tc thyroid scintigraphy (TS), and ultrasonography (USG). TBR was calculated from TS. Each patient was followed for at least six months, with final diagnoses of GD or SAT made by an endocrinologist.</div></div><div><h3>Results</h3><div>Sixty-eight and 38 patients were diagnosed with GD and SAT, respectively. The analysis of thyroid-associated laboratory markers and inflammatory indices revealed characteristic differences between GD and SAT. Multivariable logistic regression analysis revealed three independent predictors of SAT: diminished TSI (OR<!--> <!-->=<!--> <!-->0.04; <em>P</em>=.039), reduced fT3/fT4 ratio (OR<!--> <!-->=<!--> <!-->0.05; <em>P</em>=.019), and lower TBR (OR<!--> <!-->=<!--> <!-->0.20; <em>P</em>=.001). TSI demonstrated high diagnostic accuracy area under the curve (AUC): 0.923, optimal cut-off: ≤1.05 IU/L, sensitivity: 100%, specificity: 85.9%). The TBR yielded the highest AUC (0.990) in distinguishing GD from SAT (cut-off: ≤ 3.6 IU/l, sensitivity: 97.4%, specificity: 98.5%).</div><div>According to USG findings, the cases showed two different patterns as diffuse thyroiditis pattern (DTP) and nodular thyroiditis pattern (NTP). On USG a DTP was more frequent in GD group than in SAT group (80.9% <em>vs</em>. 55.3%; <em>P</em>=.007). In both GD and SAT, demographic and clinical findings were similar between patients with DTP and patients with NTP. However, symptom duration, TSI, fT3, fT3/fT4 ratio, anti-TPO, thyroid ROI and TBR levels were higher in GD patients with DTP or NTP than in SAT patients with DTP or NTP. In contrast, background ROI, ESR and CRP levels were lower. Among patients with DTP, a TBR cut-off value of ≤ 3.7 yielded a sensitivity of 95.2% and a specificity of 98.2% in distinguishing SAT from GD. In this cohort, TBR demonstrated superior diagnostic performance compared to TSI. The optimal TBR threshold for differentiating SAT from GD among patients with NTP was <<!--> <!-->2.3, exhibiting 100% sensitivity and 100% specificity. However, the diagnostic performance was not significantly different from that of TSI. A positive thyroglossal duct activity finding was p
背景与目的甲状腺毒症是内分泌科常见的临床疾病,以Graves病(GD)和亚急性甲状腺炎(SAT)为主要病因。这些疾病通常具有重叠的临床和生化特征,使得鉴别诊断具有挑战性。本研究评估了甲状腺/背景比(TBR)作为区分GD和SAT的半定量方法的诊断效果,并比较了多个诊断参数。材料与方法回顾性分析106例新诊断甲状腺毒症患者的临床资料。所有参与者均接受游离三碘甲状腺原氨酸(fT3)、游离甲状腺素(fT4)、TSH、促甲状腺免疫球蛋白(TSI)、抗tpo、抗tg、CRP、红细胞沉降率(ESR)、99mTc甲状腺显像(TS)和超声检查(USG)的评估。TBR由TS计算。每位患者至少随访6个月,最终由内分泌学家诊断为GD或SAT。结果GD患者68例,SAT患者38例。甲状腺相关实验室标志物和炎症指标分析显示GD和SAT之间的特征性差异。多变量logistic回归分析显示SAT的三个独立预测因子:TSI降低(OR = 0.04; P= 0.039), fT3/fT4比值降低(OR = 0.05; P= 0.019), TBR降低(OR = 0.20; P= 0.001)。TSI具有较高的诊断准确率,曲线下面积(AUC)为0.923,最佳截止值≤1.05 IU/L,灵敏度为100%,特异性为85.9%。TBR鉴别GD和SAT的AUC最高(0.990)(截止值≤3.6 IU/l,敏感性97.4%,特异性98.5%)。根据USG检查结果,病例表现为弥漫性甲状腺炎(DTP)和结节性甲状腺炎(NTP)两种不同的模式。在USG中,GD组DTP发生率高于SAT组(80.9% vs. 55.3%; P= 0.007)。在GD和SAT中,DTP患者和NTP患者的人口学和临床结果相似。GD合并DTP或NTP患者的症状持续时间、TSI、fT3、fT3/fT4比值、抗tpo、甲状腺ROI和TBR水平均高于SAT合并DTP或NTP患者。相比之下,背景ROI、ESR和CRP水平较低。在DTP患者中,TBR临界值≤3.7,区分SAT和GD的敏感性为95.2%,特异性为98.2%。在这个队列中,与TSI相比,TBR表现出更好的诊断性能。NTP患者区分SAT与GD的最佳TBR阈值为<; 2.3,敏感性100%,特异性100%。但其诊断性能与TSI无显著差异。甲状腺舌管活动阳性仅出现在GD患者中,占45.5%。结论fT3/fT4比值对GD和SAT的诊断效果有限,TSI具有较高的准确性,而TBR在区分SAT和GD方面的诊断准确性最高(AUC: 0.990)。根据亚组分析,DTP病例TBR的诊断准确率高于TSI,而NTP病例TBR的诊断准确率与TSI相当。
{"title":"Exactitud diagnóstica del cociente tiroides/fondo para diferenciar la enfermedad de Graves de la tiroiditis subaguda: estudio comparativo","authors":"G. Silov ,&nbsp;F. Bati ,&nbsp;N. Biçakçi ,&nbsp;B. Kirtiloğlu ,&nbsp;M. Yilmaz","doi":"10.1016/j.remn.2025.500199","DOIUrl":"10.1016/j.remn.2025.500199","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background and objective&lt;/h3&gt;&lt;div&gt;Thyrotoxicosis is a common clinical condition in endocrinology, with Graves’ disease (GD) and subacute thyroiditis (SAT) as its predominant causes. These disorders often share overlapping clinical and biochemical features, making differential diagnosis challenging. This study evaluates the diagnostic efficacy of the thyroid/background ratio (TBR) as a semiquantitative method for differentiating GD from SAT and compares multiple diagnostic parameters.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Materials and methods&lt;/h3&gt;&lt;div&gt;This was a retrospective analysis of 106 consecutive patients newly diagnosed with thyrotoxicosis. All participants underwent assessment of free tri-iodothyronine (fT3), free thyroxine (fT4), TSH, thyroid-stimulating immunoglobulin (TSI), Anti-TPO, Anti-Tg, CRP, erythrocyte sedimentation rate (ESR), &lt;sup&gt;99m&lt;/sup&gt;Tc thyroid scintigraphy (TS), and ultrasonography (USG). TBR was calculated from TS. Each patient was followed for at least six months, with final diagnoses of GD or SAT made by an endocrinologist.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Sixty-eight and 38 patients were diagnosed with GD and SAT, respectively. The analysis of thyroid-associated laboratory markers and inflammatory indices revealed characteristic differences between GD and SAT. Multivariable logistic regression analysis revealed three independent predictors of SAT: diminished TSI (OR&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.04; &lt;em&gt;P&lt;/em&gt;=.039), reduced fT3/fT4 ratio (OR&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.05; &lt;em&gt;P&lt;/em&gt;=.019), and lower TBR (OR&lt;!--&gt; &lt;!--&gt;=&lt;!--&gt; &lt;!--&gt;0.20; &lt;em&gt;P&lt;/em&gt;=.001). TSI demonstrated high diagnostic accuracy area under the curve (AUC): 0.923, optimal cut-off: ≤1.05 IU/L, sensitivity: 100%, specificity: 85.9%). The TBR yielded the highest AUC (0.990) in distinguishing GD from SAT (cut-off: ≤ 3.6 IU/l, sensitivity: 97.4%, specificity: 98.5%).&lt;/div&gt;&lt;div&gt;According to USG findings, the cases showed two different patterns as diffuse thyroiditis pattern (DTP) and nodular thyroiditis pattern (NTP). On USG a DTP was more frequent in GD group than in SAT group (80.9% &lt;em&gt;vs&lt;/em&gt;. 55.3%; &lt;em&gt;P&lt;/em&gt;=.007). In both GD and SAT, demographic and clinical findings were similar between patients with DTP and patients with NTP. However, symptom duration, TSI, fT3, fT3/fT4 ratio, anti-TPO, thyroid ROI and TBR levels were higher in GD patients with DTP or NTP than in SAT patients with DTP or NTP. In contrast, background ROI, ESR and CRP levels were lower. Among patients with DTP, a TBR cut-off value of ≤ 3.7 yielded a sensitivity of 95.2% and a specificity of 98.2% in distinguishing SAT from GD. In this cohort, TBR demonstrated superior diagnostic performance compared to TSI. The optimal TBR threshold for differentiating SAT from GD among patients with NTP was &lt;&lt;!--&gt; &lt;!--&gt;2.3, exhibiting 100% sensitivity and 100% specificity. However, the diagnostic performance was not significantly different from that of TSI. A positive thyroglossal duct activity finding was p","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 6","pages":"Article 500199"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145468999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carcinoma ductal agresivo presentado con superscan mamario bilateral en la [18F]FDG PET/TC [18F]FDG PET/TC中双侧乳腺增生的侵袭性导管癌
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-01 DOI: 10.1016/j.remn.2025.500163
Ahmed S. Abdlkadir , Enrique Estrada-Lobato , Kamal Al-Rabi , Akram Al-Ibraheem
{"title":"Carcinoma ductal agresivo presentado con superscan mamario bilateral en la [18F]FDG PET/TC","authors":"Ahmed S. Abdlkadir ,&nbsp;Enrique Estrada-Lobato ,&nbsp;Kamal Al-Rabi ,&nbsp;Akram Al-Ibraheem","doi":"10.1016/j.remn.2025.500163","DOIUrl":"10.1016/j.remn.2025.500163","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 6","pages":"Article 500163"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145468991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
El aumento de las tasas de acumulación de [18F]FDG en el cerebro de los niños podría dar lugar a que una menor cantidad de [18F]FDG llegue a otros órganos y tumores: ¿sería necesario un nuevo factor de corrección SUV que tenga en cuenta la captación de [18F]FDG en el cerebro de los niños? [18F吸积率增加]FDG儿童大脑可能导致更少的[18F] FDG,扩展到其他器官和肿瘤:¿需要新的校正因子equinox集[18F]考虑到FDG在儿童的大脑?
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-01 DOI: 10.1016/j.remn.2025.500123
E. Tatci , S.B. Schuerrle , Ö. Özmen

Objective

[18F]FDG uptake in the livers and tumors of children is lower than that of adults. The brain exhibits intense physiological [18F]FDG uptake. In childhood, the ratio of brain weight to body height and the ratio of brain weight to body weight are higher than those of adults. We hypothesized that in children, most of the [18F]FDG would be retained in the brain, resulting in less [18F]FDG activity reaching other organs and tumor tissues.

Methods

The [18F]FDG PET/CT images of 56 pediatric and 24 adult patients were evaluated retrospectively. Patients were divided into four age groups: 1) 3 to 7 years old, 2) 8 to 12 years old, 3) 13 to 17 years old, and 4) over 18 years. Accumulated [18F]FDG activity in the brain, liver, and whole body (WB) was calculated using the manually drawn volumes of interest for all patients using NUKDOS software. Also, SUV normalized to total body weight (SUVbw) and SUV normalized to lean body mass (SUVlbm) of the liver were calculated using the NUKDOS software.

Results

The mean [18F]FDG accumulation ratio of brain-to-WB was significantly higher in patients aged 3-7 years and 8-12 years than in adults. Brain/WB [18F]FDG activity ratio was lower in the 13-17 age group compared to the 3-7 age group (P=.0001). The accumulated [18F]FDG activity ratio of liver-to-WB in the 3-7 age group was significantly lower than in adults when comparing the four groups (P=.0001). The mean of liver SUVbw was statistically lower in the 3-7 and 8-12 age groups than in the 13-17 and adult groups. Patients aged 3-7 years had a significantly lower mean liver SUVlbm than those in the other age groups. The mean liver SUVlbm was also significantly lower in the 8-12 years and 13-17 years age groups than in adults. There was a negative correlation between blood glucose levels and the amount of [18F]FDG in the brain. However, no statistically significant correlation existed between blood glucose and age.

Conclusion

We showed that the [18F]FDG accumulation rate was higher in the brain and lower in the liver in the children when compared to adults. Our findings suggest that increased uptake of [18F]FDG in children's brains may lead to reduced activity reaching other organs and tumor tissue. To improve diagnostic accuracy, adapted SUV correction protocols can be developed for pediatric populations, considering age-related changes in [18F]FDG uptake ratio of the brain.
目的[18F]儿童FDG在肝脏和肿瘤中的摄取量低于成人。大脑表现出强烈的生理[18F]FDG摄取。儿童期脑重与身高之比、脑重与体重之比均高于成人。我们假设,在儿童中,大部分[18F]FDG将保留在大脑中,导致较少的[18F]FDG活性到达其他器官和肿瘤组织。方法回顾性分析56例儿童和24例成人的FDG PET/CT影像。患者分为4个年龄组:1)3 ~ 7岁,2)8 ~ 12岁,3)13 ~ 17岁,4)18岁以上。使用NUKDOS软件对所有患者手工绘制感兴趣体积,计算脑、肝和全身(WB)累积[18F]FDG活性。采用NUKDOS软件计算肝脏SUV归一化至总体重(SUVbw)和SUV归一化至瘦体重(SUVlbm)。结果3 ~ 7岁和8 ~ 12岁患者脑脑FDG / wb平均[18F]积累比明显高于成人。13-17岁年龄组的脑/脑[18F]FDG活性比低于3-7岁年龄组(P= 0.0001)。4组比较,3 ~ 7岁组肝脏与wb累积[18F]FDG活性比显著低于成人(P= 0.0001)。3-7岁和8-12岁年龄组的肝脏SUVbw平均值低于13-17岁和成人组。3-7岁患者的平均肝脏SUVlbm明显低于其他年龄组。8-12岁和13-17岁年龄组的平均肝脏SUVlbm也明显低于成人。血糖水平与脑内[18F]FDG含量呈负相关。然而,血糖与年龄之间没有统计学上的显著相关性。结论与成人相比,儿童的[18F]FDG在脑中的积累率较高,在肝脏中的积累率较低。我们的研究结果表明,儿童大脑中[18F]FDG摄取的增加可能导致到达其他器官和肿瘤组织的活动减少。为了提高诊断的准确性,可以针对儿科人群制定适应性的SUV校正方案,同时考虑脑[18F]FDG摄取比的年龄相关变化。
{"title":"El aumento de las tasas de acumulación de [18F]FDG en el cerebro de los niños podría dar lugar a que una menor cantidad de [18F]FDG llegue a otros órganos y tumores: ¿sería necesario un nuevo factor de corrección SUV que tenga en cuenta la captación de [18F]FDG en el cerebro de los niños?","authors":"E. Tatci ,&nbsp;S.B. Schuerrle ,&nbsp;Ö. Özmen","doi":"10.1016/j.remn.2025.500123","DOIUrl":"10.1016/j.remn.2025.500123","url":null,"abstract":"<div><h3>Objective</h3><div>[<sup>18</sup>F]FDG uptake in the livers and tumors of children is lower than that of adults. The brain exhibits intense physiological [<sup>18</sup>F]FDG uptake. In childhood, the ratio of brain weight to body height and the ratio of brain weight to body weight are higher than those of adults. We hypothesized that in children, most of the [<sup>18</sup>F]FDG would be retained in the brain, resulting in less [<sup>18</sup>F]FDG activity reaching other organs and tumor tissues.</div></div><div><h3>Methods</h3><div>The [<sup>18</sup>F]FDG PET/CT images of 56 pediatric and 24 adult patients were evaluated retrospectively. Patients were divided into four age groups: 1) 3 to 7 years old, 2) 8 to 12 years old, 3) 13 to 17 years old, and 4) over 18 years. Accumulated [<sup>18</sup>F]FDG activity in the brain, liver, and whole body (WB) was calculated using the manually drawn volumes of interest for all patients using NUKDOS software. Also, SUV normalized to total body weight (SUVbw) and SUV normalized to lean body mass (SUVlbm) of the liver were calculated using the NUKDOS software.</div></div><div><h3>Results</h3><div>The mean [<sup>18</sup>F]FDG accumulation ratio of brain-to-WB was significantly higher in patients aged 3-7 years and 8-12 years than in adults. Brain/WB [<sup>18</sup>F]FDG activity ratio was lower in the 13-17 age group compared to the 3-7 age group (<em>P</em>=.0001). The accumulated [<sup>18</sup>F]FDG activity ratio of liver-to-WB in the 3-7 age group was significantly lower than in adults when comparing the four groups (<em>P</em>=.0001). The mean of liver SUVbw was statistically lower in the 3-7 and 8-12 age groups than in the 13-17 and adult groups. Patients aged 3-7 years had a significantly lower mean liver SUVlbm than those in the other age groups. The mean liver SUVlbm was also significantly lower in the 8-12 years and 13-17 years age groups than in adults. There was a negative correlation between blood glucose levels and the amount of [<sup>18</sup>F]FDG in the brain. However, no statistically significant correlation existed between blood glucose and age.</div></div><div><h3>Conclusion</h3><div>We showed that the [<sup>18</sup>F]FDG accumulation rate was higher in the brain and lower in the liver in the children when compared to adults. Our findings suggest that increased uptake of [<sup>18</sup>F]FDG in children's brains may lead to reduced activity reaching other organs and tumor tissue. To improve diagnostic accuracy, adapted SUV correction protocols can be developed for pediatric populations, considering age-related changes in [<sup>18</sup>F]FDG uptake ratio of the brain.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 6","pages":"Article 500123"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145468990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estadificación en el cáncer de nasofaringe: valor pronóstico de los parámetros volumétricos de la PET/TC con [18F]FDG 鼻咽癌的发展:PET/ CT体积参数的预测值[18F]FDG
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-01 DOI: 10.1016/j.remn.2025.500160
Ç. Erol , Ö. Şahin , G. Kanyılmaz , S. Erol

Objective

The aim of our study was to determine whether volumetric parameters measured from the primary lesion and metastatic lymph node (LN) using [18F]FDG PET/CT imaging affect prognosis and survival in nasopharyngeal cancer (NPC) patients.

Material and methods

Our study included 62 patients diagnosed with NPC who underwent [18F]FDG PET/CT imaging for pre-treatment staging. SUVmax, SUVmean, MTV and TLG values were measured from the primary tumor and LN. Lymph node/primary tumor SUV ratio (NTR) was calculated. The relationships between volumetric parameters and overall survival (OS), locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS) and progression-free survival (PFS) were evaluated.

Results

LN SUVmax and LN SUVmean values were significantly higher in patients with distant metastases (P =.002 and P =.016, respectively). NTR values were significantly higher in patients with distant metastases (P=.047). The ideal LN SUVmax and SUVmean cut-off values for predicting distant metastasis in patients with LN metastasis were 16.45 and 6.5, respectively. There was a statistically significant difference between the DMFSs of the two groups when the NTR cut-off value was 0.8 (P=.047). Multivariate analysis showed that LN SUVmax, LN SUVmean and NTR were associated with DMFS (P=.003, 0.05 and 0.014, respectively), while primary tumor TLG and MTV values were associated with LRRFS (P=.035 and 0.03, respectively).

Conclusion

In conclusion, we believe that LN SUVmax, SUVmean and NTR may be prognostic indicators for distant metastasis, and MTV and TLG for locoregional recurrence.
目的:研究FDG PET/CT影像学对鼻咽癌(NPC)患者原发病灶和转移淋巴结(LN)的体积参数是否影响预后和生存。材料与方法本研究纳入62例确诊为鼻咽癌的患者,经[18F]FDG PET/CT成像进行治疗前分期。从原发肿瘤和淋巴结测量SUVmax、SUVmean、MTV和TLG值。计算淋巴结/原发肿瘤SUV比(NTR)。评估容积参数与总生存期(OS)、局部无复发生存期(LRRFS)、远处无转移生存期(DMFS)和无进展生存期(PFS)之间的关系。结果sln SUVmax和LN suv平均值在远处转移患者中显著升高(P = 0.002和P = 0.016)。远处转移患者的NTR值显著高于其他患者(P= 0.047)。预测LN转移患者远处转移的理想SUVmax和SUVmean临界值分别为16.45和6.5。NTR截断值为0.8时,两组患者dmfs差异有统计学意义(P= 0.047)。多因素分析显示,LN SUVmax、LN SUVmean和NTR与DMFS相关(P分别为0.003、0.05和0.014),原发肿瘤TLG和MTV值与LRRFS相关(P分别为0.035和0.03)。结论LN SUVmax、SUVmean和NTR可能是肿瘤远处转移的预后指标,MTV和TLG可能是肿瘤局部复发的预后指标。
{"title":"Estadificación en el cáncer de nasofaringe: valor pronóstico de los parámetros volumétricos de la PET/TC con [18F]FDG","authors":"Ç. Erol ,&nbsp;Ö. Şahin ,&nbsp;G. Kanyılmaz ,&nbsp;S. Erol","doi":"10.1016/j.remn.2025.500160","DOIUrl":"10.1016/j.remn.2025.500160","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of our study was to determine whether volumetric parameters measured from the primary lesion and metastatic lymph node (LN) using [<sup>18</sup>F]FDG PET/CT imaging affect prognosis and survival in nasopharyngeal cancer (NPC) patients.</div></div><div><h3>Material and methods</h3><div>Our study included 62 patients diagnosed with NPC who underwent [<sup>18</sup>F]FDG PET/CT imaging for pre-treatment staging. SUVmax, SUVmean, MTV and TLG values were measured from the primary tumor and LN. Lymph node/primary tumor SUV ratio (NTR) was calculated. The relationships between volumetric parameters and overall survival (OS), locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS) and progression-free survival (PFS) were evaluated.</div></div><div><h3>Results</h3><div>LN SUVmax and LN SUVmean values were significantly higher in patients with distant metastases (<em>P</em> =.002 and <em>P</em> =.016, respectively). NTR values were significantly higher in patients with distant metastases (<em>P</em>=.047). The ideal LN SUVmax and SUVmean cut-off values for predicting distant metastasis in patients with LN metastasis were 16.45 and 6.5, respectively. There was a statistically significant difference between the DMFSs of the two groups when the NTR cut-off value was 0.8 (<em>P</em>=.047). Multivariate analysis showed that LN SUVmax, LN SUVmean and NTR were associated with DMFS (<em>P</em>=.003, 0.05 and 0.014, respectively), while primary tumor TLG and MTV values were associated with LRRFS (<em>P</em>=.035 and 0.03, respectively).</div></div><div><h3>Conclusion</h3><div>In conclusion, we believe that LN SUVmax, SUVmean and NTR may be prognostic indicators for distant metastasis, and MTV and TLG for locoregional recurrence.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 6","pages":"Article 500160"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145468998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reacciones adversas mediadas por [99mTc]Tc-tetrofosmina: revisión de la literatura y análisis de informes poscomercialización [99mTc]Tc-四磷明介导的不良反应:文献综述和上市后报告分析
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-01 DOI: 10.1016/j.remn.2025.500166
S. Martins , S. Costa , M. Sousa , F. Moreira , A. Martín-Suaréz , Â. Jesus

Introduction

99mTc-tetrofosmin is a diagnostic radiopharmaceutical used to evaluate cardiac pathologies. Despite the lower incidence of reactions compared to other drugs, radiopharmaceuticals can still cause adverse reactions. For this reason, pharmacovigilance plays a crucial role in detecting, understanding, evaluating and preventing them.

Objective

This study aims to review the available literature, on the safety of 99mTc-tetrofosmin, and to analyze spontaneous adverse drug reaction reports from the European EudraVigilance database.

Methods

A literature review was conducted according to PRISMA methodology. An analysis of spontaneous notifications was carried out in EudraVigilance, until 2022.

Results

The review identified a selection of 7 articles. The most reported adverse reactions were skin irritation, strange taste in the mouth and nausea. Regarding the EudraVigilance analysis, 220 notifications were identified, accounting for 477 adverse reactions. The majority belong to males (51%), between 18-64 years (45%). Health professionals were the main reporters (84%). The most prevalent System Organ Class was “general disorders and administration site conditions” (21%) and the most reported adverse reaction was pruritus (10%). Approximately 67% of reactions were considered serious, with 6 fatal cases recorded.

Conclusion

The results demonstrated that adverse reactions associated with 99mTc-tetrofosmin do occur and should not be minimized. Over a period of 17 years, only 220 notifications were recorded, which may highlight potential challenges in pharmacovigilance for radiopharmaceuticals. Therefore, raising awareness about the importance of reporting adverse reactions is crucial.
mtc -四磷磷是一种用于评估心脏病理的诊断性放射性药物。尽管与其他药物相比,放射性药物的反应发生率较低,但仍可能引起不良反应。因此,药物警戒在发现、认识、评价和预防这些疾病方面起着至关重要的作用。目的本研究旨在回顾99mTc-tetrofosmin安全性的现有文献,并分析来自欧洲EudraVigilance数据库的自发性药物不良反应报告。方法采用PRISMA方法进行文献回顾。在欧洲警戒区对自发通报进行了分析,直到2022年。结果本综述筛选出7篇文章。报告最多的不良反应是皮肤刺激、口腔异味和恶心。关于EudraVigilance分析,确定了220份通报,占477个不良反应。大多数是男性(51%),年龄在18-64岁之间(45%)。卫生专业人员是主要的报告者(84%)。最常见的系统器官分类是“一般疾病和给药部位状况”(21%),报告最多的不良反应是瘙痒(10%)。大约67%的反应被认为是严重的,有6例死亡记录。结论99mtc -四氟氰胺相关不良反应确实存在,不应尽量减少。在17年期间,仅记录了220份通报,这可能突出了放射性药物药物警戒方面的潜在挑战。因此,提高对报告不良反应重要性的认识至关重要。
{"title":"Reacciones adversas mediadas por [99mTc]Tc-tetrofosmina: revisión de la literatura y análisis de informes poscomercialización","authors":"S. Martins ,&nbsp;S. Costa ,&nbsp;M. Sousa ,&nbsp;F. Moreira ,&nbsp;A. Martín-Suaréz ,&nbsp;Â. Jesus","doi":"10.1016/j.remn.2025.500166","DOIUrl":"10.1016/j.remn.2025.500166","url":null,"abstract":"<div><h3>Introduction</h3><div><sup>99m</sup>Tc-tetrofosmin is a diagnostic radiopharmaceutical used to evaluate cardiac pathologies. Despite the lower incidence of reactions compared to other drugs, radiopharmaceuticals can still cause adverse reactions. For this reason, pharmacovigilance plays a crucial role in detecting, understanding, evaluating and preventing them.</div></div><div><h3>Objective</h3><div>This study aims to review the available literature, on the safety of <sup>99m</sup>Tc-tetrofosmin, and to analyze spontaneous adverse drug reaction reports from the European EudraVigilance database.</div></div><div><h3>Methods</h3><div>A literature review was conducted according to PRISMA methodology. An analysis of spontaneous notifications was carried out in EudraVigilance, until 2022.</div></div><div><h3>Results</h3><div>The review identified a selection of 7 articles. The most reported adverse reactions were skin irritation, strange taste in the mouth and nausea. Regarding the EudraVigilance analysis, 220 notifications were identified, accounting for 477 adverse reactions. The majority belong to males (51%), between 18-64 years (45%). Health professionals were the main reporters (84%). The most prevalent System Organ Class was “general disorders and administration site conditions” (21%) and the most reported adverse reaction was pruritus (10%). Approximately 67% of reactions were considered serious, with 6 fatal cases recorded.</div></div><div><h3>Conclusion</h3><div>The results demonstrated that adverse reactions associated with <sup>99m</sup>Tc-tetrofosmin do occur and should not be minimized. Over a period of 17 years, only 220 notifications were recorded, which may highlight potential challenges in pharmacovigilance for radiopharmaceuticals. Therefore, raising awareness about the importance of reporting adverse reactions is crucial.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 6","pages":"Article 500166"},"PeriodicalIF":1.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145468896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista Espanola De Medicina Nuclear E Imagen Molecular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1